APOA1 and coronary artery disorder: After 3 months of smoking cessation, plasma apoA-1 levels increased more significantly in CAD-abs (0.32 ± 0.30 g/l) than in CAD-smo (0.02 ± 0.29 g/l; p = 0.032) but did not change in NCAD-abs.